InMed Pharmaceuticals Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| INM | LABS.TO | APUS | IMCC | AVCN.TO | PCLO.V | |
|---|---|---|---|---|---|---|
| Market cap | 9.61M | 29.90M | 4.41M | 1.18M | 14.78M | 11.01M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -0.3 | -7.0 | — | -0.6 | -1.8 | -1.1 |
| Price/book | 0.9 | 0.8 | 4.5 | -0.1 | 3.2 | -1.1 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −2.89% | 0.00% | −88.39% | −98.19% | −56.86% | +11.11% |
| Today | +4.17% | +16.67% | −1.68% | −1.04% | 0.00% | +10.00% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.
Latest news
All INM news ›InMed Pharmaceuticals Reports Q1 FY2027 Results, Updates Mentari Merger and Nasdaq Compliance
TradingView InMed Pharmaceuticals Reports Q1 FY2027 Results, Updates Mentari Merger and Nasdaq Compliance InMed Pharmaceuticals reported a $2.33 million first-quarter fiscal 2027 net loss and said its cash
InMed Pharmaceuticals announces 1-for-10 share consolidation
InMed Pharmaceuticals plans a 1-for-10 reverse share split tied to its Mentari merger. InMed Pharmaceuticals (INM) announced a proposed 1-for-10 reverse share split, subject to approval of three merger-related proposals at its November 4,…
Contrasting CorMedix (NASDAQ:CRMD) & InMed Pharmaceuticals (NASDAQ:INM)
Posted by Tristan Rich on Oct 22nd, 2026 InMed Pharmaceuticals (NASDAQ:INM – Get Free Report) and CorMedix (NASDAQ:CRMD – Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will compare the two…
InMed Pharmaceuticals: ADAR1 funds buy 1,086 shares
InMed Pharmaceuticals Inc. (NASDAQ: INM) is a British Columbia-based drug developer focused on proprietary small molecule CB1/CB2 programs in Alzheimer’s, ocular and dermatological indications. - [Form 4] InMed Pharmaceuticals Inc. Insider…
InMed Pharmaceuticals: ADAR1 reports 17.2% stake
Healthcare Triangle, Inc. Announces 1-for-20 Reverse Stock Split as Part of Nasdaq Compliance Plan BlackRock Capital Allocation Term Trust (BCAT) Announces Results of its Rights Offering Greenland Energy Company Announces the Resignation…
Heron Therapeutics (NASDAQ:HRTX) & InMed Pharmaceuticals (NASDAQ:INM) Head-To-Head Review
Posted by Kim Johansen on Oct 21st, 2026 InMed Pharmaceuticals (NASDAQ:INM – Get Free Report) and Heron Therapeutics (NASDAQ:HRTX – Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will…
InMed Pharmaceuticals (NASDAQ:INM) Major Shareholder Adar1 Capital Management, Llc Acquires 18,182 Shares of Stock
Posted by Defense World Staff on Oct 6th, 2026 Adar1 Capital Management, Llc also recently made the following trade(s): INM stock opened at $1.33 on Tuesday. InMed Pharmaceuticals Inc. has a 52-week low of $0.57 and a 52-week high of…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- stocktitan.net4
- themarketsdaily.com2
- defenseworld.net1
- seekingalpha.com1
- tradingview.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 9 articles, not a forecast.